Celldex Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2014 | — | -3,414.1% | -3,292.8% |
| FY2015 | — | -2,363.9% | -2,321.1% |
| FY2016 | 76.4% | -1,958.7% | -1,894.0% |
| FY2017 | 94.5% | -953.7% | -730.1% |
| FY2018 | 92.7% | -1,640.1% | -1,585.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2014 | — | -3,414.1% | -3,292.8% |
| FY2015 | — | -2,363.9% | -2,321.1% |
| FY2016 | 76.4% | -1,958.7% | -1,894.0% |
| FY2017 | 94.5% | -953.7% | -730.1% |
| FY2018 | 92.7% | -1,640.1% | -1,585.1% |